Legend Biotech (LEGN) Tax Provisions (2019 - 2025)
Legend Biotech (LEGN) posted Tax Provisions of -$616000.0 for Q3 2025, down 5.84% on a QoQ basis from -$582000.0 in Q2 2025, and up 86.11% year-over-year from -$330986.2 in Q3 2024.
Legend Biotech (LEGN) Tax Provisions (2019 - 2025) Analysis & Trends
Legend Biotech's Tax Provisions history runs 7 years deep, the most recent figure standing at -$616000.0 for Q3 2025.
- Quarterly Tax Provisions rose 86.11% year-over-year to -$616000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $20.6 million (up 419.69% YoY) and the FY2024 annual result came in at $18.9 million, up 1094.37% from the prior year.
- Tax Provisions was -$616000.0 for Q3 2025 at Legend Biotech, down from -$582000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $23.6 million in Q4 2024 and bottomed at -$4.4 million in Q3 2024.
- A 5-year average of $629687.5 and a median of -$194500.0 in 2022 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2024 — Tax Provisions surged 1431.02% — and 2025, when it sank 35620.0%.
- Legend Biotech's Tax Provisions stood at -$3.6 million in 2021, then surged by 95.65% to -$157000.0 in 2022, then plunged by 1027.39% to -$1.8 million in 2023, then jumped by 1431.02% to $23.6 million in 2024, then tumbled by 102.61% to -$616000.0 in 2025.
- Business Quant data shows LEGN's Tax Provisions at -$616000.0 in Q3 2025, -$582000.0 in Q2 2025, and -$1.8 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -616,000.00 |
| Jun 30, 2025 | -582,000.00 |
| Mar 31, 2025 | -1.79 Mn |
| Dec 31, 2024 | 23.56 Mn |
| Sep 30, 2024 | -4.44 Mn |
| Jun 30, 2024 | -226,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | -1.77 Mn |
| Sep 30, 2023 | 288,000.00 |
| Jun 30, 2023 | -290,000.00 |
| Mar 31, 2023 | -128,000.00 |
| Jun 30, 2022 | -157,000.00 |
| Mar 31, 2022 | -163,000.00 |
| Dec 31, 2021 | -3.61 Mn |
| Jun 30, 2021 | -5,082.00 |
| Mar 31, 2021 | 4,082.00 |
| Dec 31, 2020 | -72,000.00 |
| Sep 30, 2020 | 508,000.00 |
| Mar 31, 2020 | 3.71 Mn |
| Dec 31, 2019 | -2.26 Mn |